JOSEPH JACKMOVICH: Open Payments
NPI 1992326987 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 23 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $104 · 2025 $699
Food & beverage: $587Education: $111
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $173 |
| Otsuka America Pharmaceutical, Inc. | 9 | $161 |
| Teva Pharmaceuticals USA, Inc. | 4 | $147 |
| E.R. Squibb & Sons, L.L.C. | 1 | $100 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| ABBVIE INC. | 1 | $19 |
| Brainsway USA INC | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
Products named: Auvelity, REXULTI, COBENFY, AUSTEDO XR, FANAPT, CAPLYTA, VRAYLAR, Deep TMS System.
Industry payments across OR — which companies pay providers there.
